Kritika Agarwal speaks to The Hindu Business Line on indemnity for vaccine makers

by | Aug 24, 2021

Kritika Agarwal, Associate Partner – Corporate/M&A and Competition spoke to The Hindu Business Line on Indemnity for vaccine makers. According to her, “vaccine manufacturers may not want to spend time and money on defending any claims in all the countries where they supply and be subject to extensive litigation.”

Read the full article here.

More News

Kritika Agarwal speaks to Livemint on Zee-Sony Merger Deal

Kritika Agarwal spoke to LiveMint on the Zee Entertainment and Sony Pictures Entertainment merger agreement. She pointed out that the merger is subject to shareholders’ approval. “With Invesco holding almost 18% shares and assuming that it will not vote for the...

read more